Community Pharmacy Anticoagulation Monitoring Service - NHS/SOEPS/16.271 ITT

Brighton and Hove Clinical Commissioning Group are looking to commission a new Community Pharmacy Anticoagulation Monitoring Service (CPAMS) from 1st June 2018. Brighton and Hove CCG are looking to work in partnership with the successful provider to develop and deliver an innovative service throughout the contract terms, which offers its patients the best possible experience and supports the cardiovascular pathway. This may mean in the future working with several other CCG's across the Central Sussex Alliance. The new service will need to be in place by 1st June 2018. This NHS standard contract will be let for an initial 3 year period, with a single option to extend for a further 2 years (3+2). The contract envelope ceiling for the initial three year period is £2,625,000. The activity and contract values for years four or five are unknown. The tender documents are available with free, unrestricted access at: https://in-tendhost.co.uk/soepscommissioning/aspx/Home . The deadline for receipt of completed bid submissions is 12pm (midday) on Friday 19th January 2018. The Contracting Authorities look forward to receiving your submissions.

Additional information: Aims The CCG wishes to offer a clinically effective and safe, standardised anti-coagulation management service to patients receiving anti-coagulation therapy, within Brighton and Hove, offering choice and flexibility to the patient as to how and where their therapy is conducted. The service is required to enable a cohort of eligible patients to test their own INR at home. Patients will be identified using eligibility criteria outlined in the service specification. The service will then train and assess the patients' ability to use their own meter and read and record test their INR results. The service will manage and monitor individuals self-testing to ensure appropriate frequency of INR testing. The service will support patient choice and refer back to primary care where a DOAC is considered as a more preferable and appropriate option at initiation (rather than warfarin) or switching to a DOAC would be clinically preferable when identified. The service is also responsible for training of its own practitioners to the required standard to deliver the service provision of equipment and consumables, IM&T enabling read-only access for GPs. The service is responsible for ensuring consumable clinical and non-clinical equipment is stored appropriately. The service is responsible for carrying out internal clinical audit. Should the CCG require any audit information, this will be shared with the CCG in a timely manner. The CCG will provide at least 6 weeks' notice to the provider.